|
|
 |
AMMONIUM GLYCYRRHIZATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SODIUM STARCH GLYCOLATE TYPE A CORN Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SODIUM PHOSPHATE, DIBASIC Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SODIUM CITRATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AMMONIO METHACRYLATE COPOLYMER TYPE B Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SODIUM PHOSPHATE, DIBASIC, DIHYDRATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|